Vaccine against cervical cancer to begin from June: Expert, Health News, ET HealthWorld

Pune: Girls in the 9-14 age group will start getting the indigenously developed vaccine against cervical cancer for free at government sites from June this year, Dr NK Arora, head of the National Technical Advisory Group on Immunization (NTAGI), told TOI on Wednesday. The Pune-based vaccine major, Serum Institute of India (SII), launched the madein-India vaccine Cervavac on January 24. It will cost about Rs 150 per dose to the Union government and around Rs 300, Rs 350 in the private market, sources in the Union health ministry said. The…

Read More

US FDA joins global regulators probing tainted overseas cough syrup, Health News, ET HealthWorld

New York: The US Food and Drug Administration said on Wednesday it is working with the World Health Organisation and foreign regulatory authorities to support an investigation into the source of contaminated cough syrups that have killed more than 300 children in Africa and Asia. In a statement, the FDA said it had no indication that contaminated syrups had entered the US drug supply chain, but it is “investigating the potential impact and scope of this hazard on FDA-regulated products.” The agency recommended consumers only take medicines which were made…

Read More

Booster dose of Covishield offers best immune response: Lancet study, Health News, ET HealthWorld

New Delhi: A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or Covaxin, according to a new study conducted in India and published in The Lancet Regional Health Southeast Asia journal. According to the study, even though homologous and heterologous boosting with Covishield or Covaxin in Covishield or Covaxin primed individuals are immunogenic and safe, boosting with Covishield produced better binding and functional antibodies, irrespective of whether the primary vaccination series used Covishield or Covaxin. Primary SARS-CoV-2 vaccination has been…

Read More

Covid Drug: New oral antiviral drug likely to get Centre’s approval for treating Covid, Health News, ET HealthWorld

Pune: The Union health ministry is likely to include an oral antiviral drug, nirmatrelvir-ritonavir combination, in the country’s upcoming Covid treatment protocol for patients with mild to moderate disease, who are at high risk of developing severe illness. The combination drug, popularly known by the brand name paxlovid, is currently in high demand in China and a few other nations battling the Covid surge. India’s upcoming Covid treatment protocol is expected to be released within a week. “The combination two-tablet oral drug therapy is likely to be recommended in India…

Read More

World Health Organisation: WHO seeks $2.5 bn for health emergency responses in 2023, Health News, ET HealthWorld

Geneva: The World Health Organization on Monday appealed for $2.54 billion for its work in 2023 to help millions of people facing health emergencies around the world. The UN health agency said that it was currently responding to an unprecedented number of intersecting health emergencies. It pointed to the brutal war in Ukraine and the health impacts of conflicts in Yemen, Afghanistan, Syria and Ethiopia, as well as climate change-related disasters like the monster floods that hit Pakistan last year and swelling food insecurity across the Sahel and the Horn…

Read More

WHO urges ‘immediate action’ after cough syrup deaths, Health News, ET HealthWorld

London: The World Health Organization has called for “immediate and concerted action” to protect children from contaminated medicines after a spate of child deaths linked to cough syrups last year. In 2022, more than 300 children mainly aged under 5 – in Gambia, Indonesia and Uzbekistan died of acute kidney injury, in deaths that were associated with contaminated medicines, the WHO said in a statement on Monday. The medicines, over-the-counter cough syrups, had high levels of diethylene glycol and ethylene glycol. “These contaminants are toxic chemicals used as industrial solvents…

Read More

Pharmacists to become vaccinators, 12.5 lakh to get training from May, Health News, ET HealthWorld

NAGPUR: Worried about who will administer vaccines in the absence of doctors and nurses, particularly in rural areas? Now, pharmaceutical shop owners could come to your help. The Indian Pharmaceutical Association (IPA) has started an ambitious programme to turn phamacists into ‘vaccinators’ by providing training. The IPA has set a target to train all 12.5 lakh registered pharmacists in India to take up the role of vaccinators by 2025, which it feels would save at least 25% lives in a global crisis like Covid. The training would commence from May…

Read More

China making ‘enormous progress’ on vaccinating elderly: WHO, Health News, ET HealthWorld

Geneva: The World Health Organisation‘s director of immunisation on Friday praised China for making quick progress on vaccinating older people with COVID-19 shots and boosters since lifting anti-virus controls last month. “China is making enormous progress and effort to get to every older adult with both primary doses and with booster doses,” the WHO‘s Kate O’Brien told a Geneva press briefing. However, she added that some elderly people found it “difficult” to understand changes in its vaccination policy for the elderly since they had previously been advised not to seek…

Read More

India’s G20 presidency bolstering voice of Global South: Dr Alyoade Alakija, Health News, ET HealthWorld

Thiruvananthapuram: Appreciating the kickstart of India’s G20 presidency, Dr Ayoade Alakija, Special Envoy ACT-Accelerator, World Health Organisation said, “Very excited by the India G20 presidency to start off with and very keen to see the sort of global south collaboration that we can put together in this new world order. For us as a health group, this new global health order.” Speaking at the G20 India Presidency meeting in Kerala Dr Alakjia said, “The world is coming to India, not just to have a discussion, but to learn from the…

Read More

TAWS-16 Tool: NIMHANS develops first-of-its-kind tool to measure work stress, Health News, ET HealthWorld

New Delhi: Employers can now utilise the TAWS-16 tool, developed by the National Institute of Mental Health and Neurological Sciences (Nimhans), to gauge employee work-related stress. TAWS-16 is the first instrument in India to solely assess work-related stress, despite the fact that several businesses are already evaluating their employees’ stress levels in a variety of methods. Depending on the findings, organisations can alter their policies in a way that will boost productivity and the wellbeing of their workforce. The tool is free to use and is offered by Nimhans in…

Read More